Not in a fight with anyone esp Leo. I do not appreciate bogus data presentation. Let me be specific: percentages of improvement P2b instead of acknowledging the very small numbers such percentages were based upon- a real corruption of statistics.
And now: too many too content to say nothing, not one word, as CEO raises great expectations with 6/17 PR and then basically steps away from the spotlight and fails to deliver in crunch time.
There is no excuse for no updates . None He owes shareholders info about grant and papers and yet the days go by.
If we are not critical we are complacent and complicit with poor company leadership and communication
Just one opinion.
I hope, along with you that B for c works and that B UC is a success.
But to fail to question company actions as the share price goes from something to nothing is a mistake.
To say one believes the science is silly in some instances. It is like know what you own. There IS NO SCIENCE yet for B for c in humans. There is some data from labs that we have yet to really see. How does this serve our interests, or the interests of the market? For Leo to hide who does what and where and how? In vitro does predict always mean in vivo success.
We can hope for the best and that is all. And we can tell Leo that shareholders like to have more rather than less information, even as he fails to disclose it.
News 
Market Data 
Discover 
